Clinical trial
A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy…
NCT00158769 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00158769 |
|---|---|
| Title | A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers |
| Official title | An Open-Label, Non-Randomised, Pharmacokinetic, Metabolic Disposition and Safety Study of a 3 Day Continuous Infusion of GR270773 in Healthy Subjects and Subjects With Hepatic Impairment. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sepsis |
| Intervention type | Drug |
| Interventions | Intravenous GR270773 - Phospholipid emulsion |
| Enrollment | 16 |
| Start date | Mar 31, 2005 |
| Primary completion | Oct 26, 2005 |
| Completion | Oct 26, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 25, 2017 |
| Countries | Slovakia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: